{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:21:06Z","timestamp":1793503266181,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["ZK [2021]-014"],"award-info":[{"award-number":["ZK [2021]-014"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460711"],"award-info":[{"award-number":["82460711"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.phrs.2025.107895","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:25:11Z","timestamp":1754432711000},"page":"107895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Artesunate alleviates Parkinson's disease by targeting astrocyte MT2A to attenuate dopamine neuronal cuproptosis"],"prefix":"10.1016","volume":"219","author":[{"given":"Yufeng","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daidi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1122-3640","authenticated-orcid":false,"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.phrs.2025.107895_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107895_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","article-title":"The lewy body in parkinson\u2019s disease and related neurodegenerative disorders","volume":"47","author":"Wakabayashi","year":"2013","journal-title":"Mol. Neurobiol."},{"issue":"3\u20134","key":"10.1016\/j.phrs.2025.107895_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10534-006-9033-z","article-title":"Metals ions and neurodegeneration","volume":"20","author":"Molina-Holgado","year":"2007","journal-title":"BioMetals"},{"issue":"2","key":"10.1016\/j.phrs.2025.107895_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/biom10020195","article-title":"Copper ions and parkinson\u2019s disease: why is homeostasis so relevant?","volume":"10","author":"Bisaglia","year":"2020","journal-title":"Biomolecules"},{"issue":"6586","key":"10.1016\/j.phrs.2025.107895_bib5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science."},{"issue":"1","key":"10.1016\/j.phrs.2025.107895_bib6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","article-title":"Copper homeostasis and cuproptosis in health and disease","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2025.107895_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114830","article-title":"The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease","volume":"163","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.phrs.2025.107895_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18655","article-title":"FDX1 inhibits thyroid cancer malignant progression by inducing cuprotosis","volume":"9","author":"Chen","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.phrs.2025.107895_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114301","article-title":"4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer","volume":"159","author":"Yang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.phrs.2025.107895_bib10","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/biof.2052","article-title":"SP1\/CTR1-mediated oxidative stress-induced cuproptosis in intervertebral disc degeneration","volume":"50","author":"Chen","year":"2024","journal-title":"BioFactors"},{"key":"10.1016\/j.phrs.2025.107895_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/147251","article-title":"Copper and copper proteins in parkinson\u2019s disease","volume":"2014","author":"Montes","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.phrs.2025.107895_bib12","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1074\/jbc.M104728200","article-title":"Biochemical characterization of the human copper transporter Ctr1","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2025.107895_bib13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00216-005-3423-x","article-title":"Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats","volume":"383","author":"Tarohda","year":"2005","journal-title":"Anal. Bioanal. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2025.107895_bib14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s12031-020-01481-3","article-title":"Role of Metallothionein-1 and Metallothionein-2 in the neuroprotective mechanism of sevoflurane preconditioning in mice","volume":"70","author":"Liu","year":"2020","journal-title":"J. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.phrs.2025.107895_bib15","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3390\/ijms18061117","article-title":"Mammalian Metallothionein-3: new functional and structural insights","volume":"18","author":"Va\u0161\u00e1k","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.phrs.2025.107895_bib16","doi-asserted-by":"crossref","first-page":"14588","DOI":"10.1074\/jbc.M601724200","article-title":"Organization and assembly of metal-thiolate clusters in epithelium-specific metallothionein-4","volume":"281","author":"Meloni","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2025.107895_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0197-0186(94)00169-U","article-title":"Immunochemical detection of metallothionein in brain","volume":"27","author":"Nakajima","year":"1995","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.phrs.2025.107895_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000109543","article-title":"Localization of metallothionein in the mammalian central nervous system","volume":"3","author":"Blaauwgeers","year":"1994","journal-title":"Biol. Signals"},{"key":"10.1016\/j.phrs.2025.107895_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104608","article-title":"Dopaminergic neuroprotective effects of rotigotine via 5-HT1A receptors: possibly involvement of metallothionein expression in astrocytes","volume":"132","author":"Isooka","year":"2020","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.phrs.2025.107895_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77652-4","article-title":"Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection","volume":"10","author":"Kikuoka","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107895_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.nbd.2013.08.003","article-title":"Targeting 5-HT(1A) receptors in astrocytes to protect dopaminergic neurons in parkinsonian models","volume":"59","author":"Miyazaki","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2025.107895_bib22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/bcp.14474","article-title":"Advances and roadblocks in the treatment of malaria","volume":"88","author":"Hanboonkunupakarn","year":"2022","journal-title":"Br. J. Clin. Pharmcol."},{"issue":"11","key":"10.1016\/j.phrs.2025.107895_bib23","first-page":"5995","article-title":"Anticancer activity of artemisinin and its derivatives","volume":"37","author":"Slezakova","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2025.107895_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173020","article-title":"Artesunate attenuates 2, 4-dinitrochlorobenzene-induced atopic dermatitis by down-regulating Th17 cell responses in BALB\/c mice","volume":"874","author":"Bai","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107895_bib25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/jnc.15620","article-title":"Artesunate restores mitochondrial fusion-fission dynamics and alleviates neuronal injury in Alzheimer's disease models","volume":"162","author":"Qin","year":"2022","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.phrs.2025.107895_bib26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1248\/bpb.b20-00604","article-title":"Artesunate provides neuroprotection against cerebral Ischemia-Reperfusion injury via the TLR-4\/NF-\u03baB pathway in rats","volume":"44","author":"Chen","year":"2021","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phrs.2025.107895_bib27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3389\/fneur.2018.00634","article-title":"Protectiveness of artesunate given prior ischemic cerebral infarction is mediated by increased autophagy","volume":"9","author":"Shao","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.phrs.2025.107895_bib28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3389\/fneur.2018.00590","article-title":"Neuroprotective effect of artesunate in experimental model of traumatic brain injury","volume":"9","author":"Gugliandolo","year":"2018","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.phrs.2025.107895_bib29","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.4103\/1673-5374.255960","article-title":"More than anti-malarial agents: therapeutic potential of artemisinins in neurodegeneration","volume":"14","author":"Lu","year":"2019","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.phrs.2025.107895_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12964-021-00737-8","article-title":"The emerging role of the KCTD proteins in cancer","volume":"19","author":"Angrisani","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.phrs.2025.107895_bib31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/978-1-0716-3662-6_36","article-title":"Ion channels and metal ions in parkinson\u2019s disease: historical perspective to the current scenario","volume":"2761","author":"Vaidya","year":"2024","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107895_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1515\/bmc-2012-0049","article-title":"Metallothionein-protein interactions","volume":"4","author":"Atrian","year":"2013","journal-title":"Biomol. Concepts"},{"issue":"9","key":"10.1016\/j.phrs.2025.107895_bib33","first-page":"1483","volume":"17","author":"Ling","year":"2016","journal-title":"Mammalian Metallothionein-2A and oxidative stress, Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2025.107895_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10048-011-0294-5","article-title":"Up-regulation of metallothionein gene expression in parkinsonian astrocytes","volume":"12","author":"Michael","year":"2011","journal-title":"Neurogenetics"},{"issue":"2","key":"10.1016\/j.phrs.2025.107895_bib35","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1471-4159.2003.02193.x","article-title":"Neuron-glia communication: metallothionein expression is specifically up-regulated by astrocytes in response to neuronal injury","volume":"88","author":"Chung","year":"2004","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.phrs.2025.107895_bib36","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1021\/ac203112c","article-title":"Combined elemental and biomolecular mass spectrometry imaging for probing the inventory of tissue at a micrometer scale","volume":"84","author":"Matusch","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.phrs.2025.107895_bib37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fnins.2017.00114","article-title":"Metallothionein, copper and alpha-synuclein in alpha-synucleinopathies","volume":"11","author":"Okita","year":"2017","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107895_bib38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41531-025-00949-6","article-title":"Sex differences in peripheral and central dysregulation of the kynurenine pathway in parkinson\u2019s disease","volume":"11","author":"Jellen","year":"2025","journal-title":"NPJ Parkinson\u2019s Dis."},{"issue":"1","key":"10.1016\/j.phrs.2025.107895_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13293-025-00692-w","article-title":"Sex and gender differences in the molecular etiology of parkinson\u2019s disease: considerations for study design and data analysis","volume":"16","author":"Schaffner","year":"2025","journal-title":"Biol. Sex. Differ."},{"issue":"1","key":"10.1016\/j.phrs.2025.107895_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40120-024-00687-6","article-title":"Sex differences in parkinson\u2019s disease: a narrative review","volume":"14","author":"Cattaneo","year":"2025","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.phrs.2025.107895_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115080","article-title":"Spatial analysis of drug absorption, distribution, metabolism, and toxicology using mass spectrometry imaging","volume":"201","author":"Spruill","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107895_bib42","first-page":"184","volume":"11","author":"Jendoubi","year":"2021","journal-title":"Approaches to integrating metabolomics and Multi-Omics data: a primer, Metabolites"},{"issue":"11","key":"10.1016\/j.phrs.2025.107895_bib43","doi-asserted-by":"crossref","first-page":"848.","DOI":"10.3390\/biology13110848","article-title":"Integrating molecular perspectives: strategies for comprehensive multi-omics integrative data analysis and machine learning applications in transcriptomics proteomics and metabolomics","volume":"13","author":"Sanches","year":"2024","journal-title":"Biology."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:51:19Z","timestamp":1772880679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825003202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"alternative-id":["S1043661825003202"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107895","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artesunate alleviates Parkinson's disease by targeting astrocyte MT2A to attenuate dopamine neuronal cuproptosis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107895","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107895"}}